BioBoston CRO (operating as BioBoston Consulting) is a boutique clinical research organisation and consulting firm operating from the greater Boston, Massachusetts area — one of the world’s most concentrated life sciences ecosystems. The company positions itself as a senior, flexible CRO services provider rather than a conventional full-service CRO, delivering focused clinical research expertise to sponsors who require experienced, accountable support without the overhead and rigidity of large CRO infrastructure.

The company’s operating model is built around a clear sponsor-accountability principle: each engagement defines the delivery model before work begins, ensuring that responsibilities between sponsor, BioBoston specialists, any third-party CROs, and partner vendors are unambiguous from the outset. This model is designed for biotechnology, pharmaceutical, medical device, and diagnostic organisations that need senior functional expertise to strengthen or supplement an existing clinical programme, manage a CRO on their behalf, or execute defined workstreams within a hybrid delivery arrangement.

BioBoston also offers CRO selection and qualification services — functioning as an independent adviser to sponsors evaluating and overseeing external CRO partners — which positions it simultaneously as a CRO delivering services directly and as a consultant supporting sponsors in managing their broader CRO ecosystem.

Key Products and Services

Clinical Research Services

• Clinical study management — study start-up, site selection, monitoring plan design, and clinical operations oversight across all phases
• Clinical trial monitoring — on-site and remote monitoring with an ICH-GCP-focused, risk-based approach; inspection-readiness maintained throughout
• Project management — programme and study-level project management with clear milestone accountability and sponsor-side governance

Regulatory Affairs

• Regulatory strategy and submission support for FDA, EMA, and other competent authorities
• IND, NDA, BLA, and 510(k) preparation and management; regulatory consulting for medical devices and diagnostics
• Pre-submission meeting preparation and agency interaction support

Clinical Quality Assurance

• GCP audit services — site audits, vendor audits, and internal system audits
• Inspection readiness preparation and remediation support
• SOP development and quality management system advisory

Data Management and Biostatistics

• Clinical data management including eCRF design, data review, medical coding, and database lock
• Statistical analysis plans, sample size calculations, and final statistical reporting
• CDISC compliance (SDTM, ADaM) and regulatory submission datasets

Medical Writing

• Clinical study protocols, clinical study reports (CSRs), investigator brochures, informed consent forms, and regulatory submission documents

CRO Selection and Qualification

• Independent CRO identification, qualification, and governance services for life sciences sponsors
• RFP management, proposal evaluation, and CRO performance oversight on behalf of sponsor organisations
• Ongoing CRO oversight and escalation management throughout clinical programmes

Therapeutic Area Coverage

Biotechnology, pharmaceutical, medical device, and diagnostic programmes across a broad range of therapeutic areas, with expertise in MedTech clinical development, including EU MDR-aligned clinical investigation design and management.

BioBoston CRO occupies the senior boutique segment of the clinical research services market, targeting sponsors who require experienced, flexible functional support rather than a full-service CRO managing every aspect of trial delivery. Its Boston location situates it within immediate reach of a dense concentration of early-stage biotech and mid-sized pharmaceutical companies whose clinical programmes are frequently underserved by large global CROs — where senior attention is reserved for the largest accounts — and whose internal teams lack the bandwidth or specialist expertise to manage all functional areas in-house. The company’s dual positioning as both a CRO service provider and an independent CRO selection and oversight adviser is an unusual commercial model that may resonate with sponsors navigating complex multi-vendor arrangements or dissatisfied with incumbent CRO performance.